{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T02:37:51Z","timestamp":1780367871654,"version":"3.54.1"},"reference-count":37,"publisher":"Spandidos Publications","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int J Mol Med"],"DOI":"10.3892\/ijmm.2018.3646","type":"journal-article","created":{"date-parts":[[2018,4,30]],"date-time":"2018-04-30T07:33:02Z","timestamp":1525073582000},"source":"Crossref","is-referenced-by-count":3,"title":["Xanthatin inhibits corneal neovascularization by inhibiting the VEGFR2\u2011mediated STAT3\/PI3K\/Akt signaling pathway"],"prefix":"10.3892","author":[{"given":"Mei","family":"Shen","sequence":"first","affiliation":[{"name":"Department of Ophthalmology, The First Affiliated Hospital of Nanchang University, Jiangxi Province Clinical Ophthalmology Institute, Nanchang, Jiangxi 330006, P.R.\u00ef\u00bf\u00bdChina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue\u2011Zhi","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Xiangya Hospital, Central South University, Changsha, Hunan 410008, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Ye","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, The First Affiliated Hospital of Nanchang University, Jiangxi Province Clinical Ophthalmology Institute, Nanchang, Jiangxi 330006, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Yuan","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, The First Affiliated Hospital of Nanchang University, Jiangxi Province Clinical Ophthalmology Institute, Nanchang, Jiangxi 330006, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ce","family":"Shi","sequence":"additional","affiliation":[{"name":"School of Ophthalmology and Optometry, Wenzhou Medical University, Wenzhou, Zhejiang 325035, P.R.\u00ef\u00bf\u00bdChina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei\u2011Wen","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, The First Affiliated Hospital of Nanchang University, Jiangxi Province Clinical Ophthalmology Institute, Nanchang, Jiangxi 330006, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, The First Affiliated Hospital of Nanchang University, Jiangxi Province Clinical Ophthalmology Institute, Nanchang, Jiangxi 330006, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming\u2011Yang","family":"Ma","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, The First Affiliated Hospital of Nanchang University, Jiangxi Province Clinical Ophthalmology Institute, Nanchang, Jiangxi 330006, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi\u2011Chen","family":"Yang","sequence":"additional","affiliation":[{"name":"Eye Institute of Xiamen University, Xiamen, Fujian 361102, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Shao","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, The First Affiliated Hospital of Nanchang University, Jiangxi Province Clinical Ophthalmology Institute, Nanchang, Jiangxi 330006, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2018,4,30]]},"reference":[{"key":"key20200713175357_b1-ijmm-42-02-0769","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.preteyeres.2010.01.002","article-title":"Novel aspects of corneal angiogenic and lymphangiogenic privilege","volume":"29","author":"Ellenberg","year":"2010","journal-title":"Prog Retin Eye Res"},{"issue":"5 Suppl","key":"key20200713175357_b2-ijmm-42-02-0769","doi-asserted-by":"publisher","first-page":"S18","DOI":"10.4269\/ajtmh.2003.69.18","article-title":"Blinding trachoma: Prevention with the safe strategy","volume":"69","author":"West","year":"2003","journal-title":"Am J Trop Med Hyg"},{"key":"key20200713175357_b3-ijmm-42-02-0769","article-title":"Flora Europea. Volume 4","volume-title":"Plantaginaceae to Compositae (and Rubiaceae)","author":"Tutin","year":"1976"},{"key":"key20200713175357_b4-ijmm-42-02-0769","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.ejmech.2014.11.060","article-title":"Optimization of xanthatin extraction from Xanthium spinosum L. and its cytotoxic, anti-angiogenesis and antiviral properties","volume":"90","author":"Romero","year":"2015","journal-title":"Eur J Med Chem"},{"key":"key20200713175357_b5-ijmm-42-02-0769","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1016\/j.phymed.2013.03.006","article-title":"Characterization of xanthatin: Anticancer properties and mechanisms of inhibited murine melanoma in vitro and in vivo","volume":"20","author":"Li","year":"2013","journal-title":"Phytomedicine"},{"key":"key20200713175357_b6-ijmm-42-02-0769","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.bcp.2016.06.009","article-title":"Xanthatin anti-tumor cytotoxicity is mediated via glycogen synthase kinase-3\u03b2 and \u03b2-catenin","volume":"115","author":"Tao","year":"2016","journal-title":"Biochem Pharmacol"},{"key":"key20200713175357_b7-ijmm-42-02-0769","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1080\/14756360500213231","article-title":"Synthesis of reduced xanthatin derivatives and in vitro evaluation of their antifungal activity","volume":"20","author":"Pinel","year":"2005","journal-title":"J Enzyme Inhib Med Chem"},{"key":"key20200713175357_b8-ijmm-42-02-0769","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1007\/s00436-011-2611-1","article-title":"Antiplasmodial activity of Xanthium strumarium against Plasmodium berghei-infected BALB\/c mice","volume":"110","author":"Chandel","year":"2012","journal-title":"Parasitol Res"},{"key":"key20200713175357_b9-ijmm-42-02-0769","doi-asserted-by":"crossref","first-page":"26988","DOI":"10.1016\/S0021-9258(18)47116-5","article-title":"Different signal transduction properties of KDR and Flt1, two receptors for vascular endothelial growth factor","volume":"269","author":"Waltenberger","year":"1994","journal-title":"J Biol Chem"},{"key":"key20200713175357_b10-ijmm-42-02-0769","doi-asserted-by":"publisher","first-page":"7533","DOI":"10.1073\/pnas.90.16.7533","article-title":"Fetal liver kinase 1 is a receptor for vascular endothelial growth factor and is selectively expressed in vascular endothelium","volume":"90","author":"Quinn","year":"1993","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20200713175357_b11-ijmm-42-02-0769","doi-asserted-by":"publisher","first-page":"3222","DOI":"10.1074\/jbc.M002016200","article-title":"Analysis of biological effects and signaling properties of Flt-1 (VEGFR-1) and KDR (VEGFR-2). A reassessment using novel receptor-specific vascular endothelial growth factor mutants","volume":"276","author":"Gille","year":"2001","journal-title":"J Biol Chem"},{"key":"key20200713175357_b12-ijmm-42-02-0769","doi-asserted-by":"publisher","first-page":"31047","DOI":"10.1074\/jbc.274.43.31047","article-title":"Vascular endothelial growth factor effect on endothelial cell proliferation, migration, and platelet-activating factor synthesis is Flk-1-dependent","volume":"274","author":"Bernatchez","year":"1999","journal-title":"J Biol Chem"},{"key":"key20200713175357_b13-ijmm-42-02-0769","first-page":"10355","article-title":"Xanthatin, a novel potent inhibitor of VEGFR2 signaling, inhibits angiogenesis and tumor growth in breast cancer cells","volume":"8","author":"Yu","year":"2015","journal-title":"Int J Clin Exp Pathol"},{"key":"key20200713175357_b14-ijmm-42-02-0769","doi-asserted-by":"publisher","first-page":"4082","DOI":"10.1073\/pnas.91.9.4082","article-title":"Thalidomide is an inhibitor of angiogenesis","volume":"91","author":"D'Amato","year":"1994","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20200713175357_b15-ijmm-42-02-0769","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.survophthal.2012.01.007","article-title":"Corneal neovascularization: An anti-VEGF therapy review","volume":"57","author":"Chang","year":"2012","journal-title":"Surv Ophthalmol"},{"key":"key20200713175357_b16-ijmm-42-02-0769","first-page":"1087","article-title":"Leukocytes and experimental corneal vascularization","volume":"17","author":"Eliason","year":"1978","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"key20200713175357_b17-ijmm-42-02-0769","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.brainresbull.2009.05.019","article-title":"Corneal transparency: Genesis, maintenance and dysfunction","volume":"81","author":"Qazi","year":"2010","journal-title":"Brain Res Bull"},{"key":"key20200713175357_b18-ijmm-42-02-0769","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1016\/j.ajo.2005.07.024","article-title":"The impact of corneal allograft rejection on the long-term outcome of corneal transplantation","volume":"140","author":"Coster","year":"2005","journal-title":"Am J Ophthalmol"},{"key":"key20200713175357_b19-ijmm-42-02-0769","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.1002\/ptr.3651","article-title":"Biological activities of xanthatin from xanthium strumarium leaves","volume":"25","author":"Nibret","year":"2011","journal-title":"Phytother Res"},{"key":"key20200713175357_b20-ijmm-42-02-0769","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1055\/s-0032-1328482","article-title":"Cytotoxic sesquiterpene lactones from aerial parts of xanthium sibiricum","volume":"79","author":"Wang","year":"2013","journal-title":"Planta Med"},{"key":"key20200713175357_b21-ijmm-42-02-0769","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.mvr.2012.02.006","article-title":"PEDF-derived peptide inhibits corneal angiogenesis by suppressing VEGF expression","volume":"84","author":"Matsui","year":"2012","journal-title":"Microvasc Rec"},{"key":"key20200713175357_b22-ijmm-42-02-0769","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1055\/s-2006-959537","article-title":"Cytotoxic activity of xanthatin and the crude extracts of xanthium strumarium","volume":"60","author":"Roussakis","year":"1994","journal-title":"Planta Med"},{"key":"key20200713175357_b23-ijmm-42-02-0769","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1002\/jcp.10026","article-title":"Novel mechanism for age-related macular degeneration: An equilibrium shift between the angiogenesis factors VEGF and PEDF","volume":"189","author":"Ohno-Matsui","year":"2001","journal-title":"J Cell Physiol"},{"key":"key20200713175357_b24-ijmm-42-02-0769","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1210\/er.2003-0027","article-title":"Vascular endothelial growth factor: Basic science and clinical progress","volume":"25","author":"Ferrara","year":"2004","journal-title":"Endocr Rev"},{"key":"key20200713175357_b25-ijmm-42-02-0769","doi-asserted-by":"publisher","first-page":"e94205","DOI":"10.1371\/journal.pone.0094205","article-title":"Mechanisms controlling the effects of bevacizumab (avastin) on the inhibition of early but not late formed corneal neovascularization","volume":"9","author":"Chen","year":"2014","journal-title":"PLoS One"},{"key":"key20200713175357_b26-ijmm-42-02-0769","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.coi.2008.03.010","article-title":"Role of Stat3 in suppressing anti-tumor immunity","volume":"20","author":"Kortylewski","year":"2008","journal-title":"Curr Opin Immunol"},{"key":"key20200713175357_b27-ijmm-42-02-0769","doi-asserted-by":"publisher","first-page":"R113","DOI":"10.1530\/ERC-13-0054","article-title":"Cardiac hormones for the treatment of cancer","volume":"20","author":"Vesely","year":"2013","journal-title":"Endocr Relat Cancer"},{"key":"key20200713175357_b28-ijmm-42-02-0769","first-page":"1459","article-title":"Family of peptides synthesized in the human body have anticancer effects","volume":"34","author":"Vesely","year":"2014","journal-title":"Anticancer Res"},{"key":"key20200713175357_b29-ijmm-42-02-0769","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.ccell.2015.06.009","article-title":"VEGF-mediated induction of RD1-BF1\/Blimp1 expression sensitizes tumor vasculature to oncolytic virus infection","volume":"28","author":"Arulanandam","year":"2015","journal-title":"Cancer Cell"},{"key":"key20200713175357_b30-ijmm-42-02-0769","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1016\/j.ajpath.2013.12.023","article-title":"VEGFA activates erythropoietin receptor and enhances VEGFR2-mediated pathological angiogenesis","volume":"184","author":"Yang","year":"2014","journal-title":"Am J Pathol"},{"key":"key20200713175357_b31-ijmm-42-02-0769","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.biopha.2013.03.020","article-title":"Pentoxifylline inhibits melanoma tumor growth and angiogenesis by targeting STAT3 signaling pathway","volume":"67","author":"Kamran","year":"2013","journal-title":"Biomed Pharmacother"},{"key":"key20200713175357_b32-ijmm-42-02-0769","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.bbapap.2007.10.003","article-title":"Targeting phosphoinositide 3-kinase: Moving towards therapy","volume":"1784","author":"Marone","year":"2008","journal-title":"Biochim Biophys Acta"},{"key":"key20200713175357_b33-ijmm-42-02-0769","doi-asserted-by":"publisher","first-page":"2959","DOI":"10.2337\/diabetes.52.12.2959","article-title":"Activation of vascular endothelial growth factor receptor-1 sustains angiogenesis and Bcl-2 expression via the phosphatidylinositol 3-kinase pathway in endothelial cells","volume":"52","author":"Cai","year":"2003","journal-title":"Diabetes"},{"key":"key20200713175357_b34-ijmm-42-02-0769","doi-asserted-by":"publisher","first-page":"e7867","DOI":"10.1371\/journal.pone.0007867","article-title":"Selective inhibition of retinal angiogenesis by targeting PI3 kinase","volume":"4","author":"Alvarez","year":"2009","journal-title":"PLoS One"},{"key":"key20200713175357_b35-ijmm-42-02-0769","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/1756-8722-7-13","article-title":"Signaling pathways in the development of infantile hemangioma","volume":"7","author":"Ji","year":"2014","journal-title":"J Hematol Oncol"},{"key":"key20200713175357_b36-ijmm-42-02-0769","doi-asserted-by":"publisher","first-page":"2221","DOI":"10.1517\/14656566.2013.832202","article-title":"Targeting angiogenesis in renal cell carcinoma","volume":"14","author":"Posadas","year":"2013","journal-title":"Expert Opin Pharmacother"},{"key":"key20200713175357_b37-ijmm-42-02-0769","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1038\/aps.2017.5","article-title":"New knowledge of the mechanisms of sorafenib resistance in liver cancer","volume":"38","author":"Zhu","year":"2017","journal-title":"Acta Pharmacol Sin"}],"container-title":["International Journal of Molecular Medicine"],"original-title":[],"deposited":{"date-parts":[[2022,8,21]],"date-time":"2022-08-21T10:26:23Z","timestamp":1661077583000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/ijmm.2018.3646"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,30]]},"references-count":37,"URL":"https:\/\/doi.org\/10.3892\/ijmm.2018.3646","relation":{},"ISSN":["1107-3756","1791-244X"],"issn-type":[{"value":"1107-3756","type":"print"},{"value":"1791-244X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,30]]}}}